Literature DB >> 15351063

A validated solid-phase extraction HPLC method for the simultaneous determination of the citrus flavanone aglycones hesperetin and naringenin in urine.

Feras Imad Kanaze1, Eugene Kokkalou, Manolis Georgarakis, Ioannis Niopas.   

Abstract

A simple, specific, precise, accurate, and robust HPLC assay for the simultaneous analysis of hesperetin and naringenin in human urine was developed and validated. Urine samples were incubated with beta-glucuronidase/sulphatase and the analytes were isolated by solid-phase extraction using C18 cartridges and separated on a C8 reversed phase column using a mixture of methanol/water/acetic acid (40:58:2, v/v/v) at 45 degrees C. The method was found to be linear in the 50-1200 ng/ml concentration range for both hesperetin and naringenin (r > 0.999). The accuracy of the method was greater than 94.8%, while the intra- and inter-day precision for hesperetin was better than 4.9 and 8.2%, respectively and for naringenin was better than 5.3 and 7.8%, respectively. Recovery for hesperetin, naringenin and internal standard 7-ethoxycoumarin was greater than 70.9%. The method has been applied for the determination of hesperetin and naringenin in urine samples obtained from a male volunteer following a single 300 mg oral dose of each of the corresponding flavanone glycosides hesperidin and naringin. The intra- and inter-day reproducibility through enzyme hydrolysis was less than 3.9% for both total (free + conjugated) hesperetin and naringenin. Stability studies showed urine quality control samples to be stable for both hesperetin and naringenin through three freeze-thaw cycles and at room temperature for 24 h (error < or = 3.6%).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15351063     DOI: 10.1016/j.jpba.2004.05.015

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  4 in total

1.  In-vitro evaluation of bioactive compounds, anti-oxidant, lipid peroxidation and lipoxygenase inhibitory potential of Citrus karna L. peel extract.

Authors:  Jagdeep Singh; Shailja Sood; Arunachalam Muthuraman
Journal:  J Food Sci Technol       Date:  2011-08-17       Impact factor: 2.701

Review 2.  A Review on Pharmacological and Analytical Aspects of Naringenin.

Authors:  Kanika Patel; Gireesh Kumar Singh; Dinesh Kumar Patel
Journal:  Chin J Integr Med       Date:  2014-12-10       Impact factor: 1.978

3.  Phenolic Compounds Present Schinus terebinthifolius Raddi Influence the Lowering of Blood Pressure in Rats.

Authors:  Lorena de Lima Glória; Mariana Barreto de Souza Arantes; Silvia Menezes de Faria Pereira; Guilherme de Souza Vieira; Camilla Xavier Martins; Almir Ribeiro de Carvalho Junior; Fernanda Antunes; Raimundo Braz-Filho; Ivo José Curcino Vieira; Larissa Leandro da Cruz; Douglas Siqueira de Almeida Chaves; Silvério de Paiva Freitas; Daniela Barros de Oliveira
Journal:  Molecules       Date:  2017-10-23       Impact factor: 4.411

4.  Development and Validation of Liquid Chromatographic Method for Estimation of Naringin in Nanoformulation.

Authors:  Kranti P Musmade; M Trilok; Swapnil J Dengale; Krishnamurthy Bhat; M S Reddy; Prashant B Musmade; N Udupa
Journal:  J Pharm (Cairo)       Date:  2014-03-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.